No Data
No Data
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
Voyager Therapeutics Executives Cash In: Major Stock Sales Revealed!
Insider Sale: Chief Scientific Officer of $VYGR Sells 5,413 Shares
Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now
Wells Fargo Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Cuts Target Price to $12
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Staar Surgical (STAA) and Hyperfine (HYPR)